dl-PHPBAlternative Names: Potassium 2-(1-hydroxypentyl)-benzoate (PHPB)
Latest Information Update: 01 Mar 2016
At a glance
- Originator Institute of Materia Medica
- Class Benzoates
- Mechanism of Action NMDA receptor modulators; Synaptic transmission modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Stroke
Most Recent Events
- 01 Mar 2016 Phase-I clinical trials in Stroke in China (unspecified route)